Atherectomy Devices - Global Market Outlook (2016-2022)

  • ID: 4428489
  • Report
  • Region: Global
  • 139 pages
  • Stratistics Market Research Consulting Pvt Ltd
UP TO OFF
until Jan 31st 2019
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

FEATURED COMPANIES

  • Abott Laboratories
  • Avinger Inc.
  • Bayer AG
  • C. R. Bard, Inc.
  • Cardinal Health (Cordis)
  • Covidien
  • MORE
According to MRC, the Global Atherectomy Devices market is accounted for $496.54 million in 2016 and is expected to reach $812.35 million by 2022 growing at a CAGR of 8.6% during the forecast period 2016 to 2022. High prevalence of Peripheral Artery Disease (PAD) across the globe is creating opportunities in the present market scenario. The market is presently consumed by demand for Minimally Invasive Surgeries (MIS). The lesser consequences of traumas across patients and quicker recovery than other procedures are acting as drivers for the market of Atherectomy Devices.

Rotational Atherectomy device segment is expected to dominate the market over the forecast period. Favorable reimbursement scenari-is attributing the market towards growth. North America market is expected to dominate the regional segment on account of high number of approved FDA devices and suitable reimbursement scenario. Moreover, Asia Pacific is expected to grow at highest CAGR, prevailing to socio-economic changes and growing number of geriatric population.

Some of the key players of the Atherectomy Devices market include Abbott Laboratories, Avinger Inc., Bayer AG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health (Cordis), Cardiovascular Systems Inc., Cordis Corporation (Subsidiary of J&J), Covidien, Medtronic plc., Spectranetics, ST. Jude Medical, Straub Medical AG, Terum-Medical Corporation and Volcan-Corporation

Technologies Covered:
  • Directional Atherectomy Devices
  • Laser Atherectomy Devices
  • Orbital Atherectomy Devices
  • Rotational Atherectomy Sevices
Disease Sites covered:
  • Coronary artery disease
  • Peripheral artery disease
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of APAC
  • Rest of the World
  • Middle East
  • Brazil
  • Argentina
  • South Africa
  • Egypt
What The Report Offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abott Laboratories
  • Avinger Inc.
  • Bayer AG
  • C. R. Bard, Inc.
  • Cardinal Health (Cordis)
  • Covidien
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Atherectomy Devices Market, By Technology
5.1 Introduction
5.2 Directional Atherectomy Devices
5.3 Laser Atherectomy Devices
5.4 Orbital Atherectomy Devices
5.5 Rotational Atherectomy Sevices

6 Global Atherectomy Devices Market, By Disease Site
6.1 Introduction
6.2 Coronary artery disease
6.3 Peripheral artery disease

7 Global Atherectomy Devices Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Abbott Laboratories
9.2 Avinger Inc.
9.3 Bayer AG
9.4 Boston Scientific Corporation
9.5 C. R. Bard, Inc.
9.6 Cardinal Health (Cordis)
9.7 Cardiovascular Systems Inc.
9.8 Cordis Corporation (Subsidiary of J&J)
9.9 Covidien
9.10 Medtronic plc.
9.11 Spectranetics
9.12 ST. JUDE MEDICAL
9.13 Straub Medical AG
9.14 Terumo Medical Corporation
9.15 VOLCANO CORPORATION

List of Tables

Table 1 Global Atherectomy Devices Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Atherectomy Devices Market Outlook, By Technology (2014-2022) ($MN)
Table 3 Global Atherectomy Devices Market Outlook, By Directional Atherectomy Devices (2014-2022) ($MN)
Table 4 Global Atherectomy Devices Market Outlook, By Laser Atherectomy Devices (2014-2022) ($MN)
Table 5 Global Atherectomy Devices Market Outlook, By Orbital Atherectomy Devices (2014-2022) ($MN)
Table 6 Global Atherectomy Devices Market Outlook, By Rotational Atherectomy Sevices (2014-2022) ($MN)
Table 7 Global Atherectomy Devices Market Outlook, By Disease Site (2014-2022) ($MN)
Table 8 Global Atherectomy Devices Market Outlook, By Coronary artery disease (2014-2022) ($MN)
Table 9 Global Atherectomy Devices Market Outlook, By Peripheral artery disease (2014-2022) ($MN)
Table 10 North America Atherectomy Devices Market Outlook, By Country (2014-2022) ($MN)
Table 11 North America Atherectomy Devices Market Outlook, By Technology (2014-2022) ($MN)
Table 12 North America Atherectomy Devices Market Outlook, By Directional Atherectomy Devices (2014-2022) ($MN)
Table 13 North America Atherectomy Devices Market Outlook, By Laser Atherectomy Devices (2014-2022) ($MN)
Table 14 North America Atherectomy Devices Market Outlook, By Orbital Atherectomy Devices (2014-2022) ($MN)
Table 15 North America Atherectomy Devices Market Outlook, By Rotational Atherectomy Sevices (2014-2022) ($MN)
Table 16 North America Atherectomy Devices Market Outlook, By Disease Site (2014-2022) ($MN)
Table 17 North America Atherectomy Devices Market Outlook, By Coronary artery disease (2014-2022) ($MN)
Table 18 North America Atherectomy Devices Market Outlook, By Peripheral artery disease (2014-2022) ($MN)
Table 19 Europe Atherectomy Devices Market Outlook, By Country (2014-2022) ($MN)
Table 20 Europe Atherectomy Devices Market Outlook, By Technology (2014-2022) ($MN)
Table 21 Europe Atherectomy Devices Market Outlook, By Directional Atherectomy Devices (2014-2022) ($MN)
Table 22 Europe Atherectomy Devices Market Outlook, By Laser Atherectomy Devices (2014-2022) ($MN)
Table 23 Europe Atherectomy Devices Market Outlook, By Orbital Atherectomy Devices (2014-2022) ($MN)
Table 24 Europe Atherectomy Devices Market Outlook, By Rotational Atherectomy Sevices (2014-2022) ($MN)
Table 25 Europe Atherectomy Devices Market Outlook, By Disease Site (2014-2022) ($MN)
Table 26 Europe Atherectomy Devices Market Outlook, By Coronary artery disease (2014-2022) ($MN)
Table 27 Europe Atherectomy Devices Market Outlook, By Peripheral artery disease (2014-2022) ($MN)
Table 28 Asia Pacific Atherectomy Devices Market Outlook, By Country (2014-2022) ($MN)
Table 29 Asia Pacific Atherectomy Devices Market Outlook, By Technology (2014-2022) ($MN)
Table 30 Asia Pacific Atherectomy Devices Market Outlook, By Directional Atherectomy Devices (2014-2022) ($MN)
Table 31 Asia Pacific Atherectomy Devices Market Outlook, By Laser Atherectomy Devices (2014-2022) ($MN)
Table 32 Asia Pacific Atherectomy Devices Market Outlook, By Orbital Atherectomy Devices (2014-2022) ($MN)
Table 33 Asia Pacific Atherectomy Devices Market Outlook, By Rotational Atherectomy Sevices (2014-2022) ($MN)
Table 34 Asia Pacific Atherectomy Devices Market Outlook, By Disease Site (2014-2022) ($MN)
Table 35 Asia Pacific Atherectomy Devices Market Outlook, By Coronary artery disease (2014-2022) ($MN)
Table 36 Asia Pacific Atherectomy Devices Market Outlook, By Peripheral artery disease (2014-2022) ($MN)
Table 37 RoW Atherectomy Devices Market Outlook, By Country (2014-2022) ($MN)
Table 38 RoW Atherectomy Devices Market Outlook, By Technology (2014-2022) ($MN)
Table 39 RoW Atherectomy Devices Market Outlook, By Directional Atherectomy Devices (2014-2022) ($MN)
Table 40 RoW Atherectomy Devices Market Outlook, By Laser Atherectomy Devices (2014-2022) ($MN)
Table 41 RoW Atherectomy Devices Market Outlook, By Orbital Atherectomy Devices (2014-2022) ($MN)
Table 42 RoW Atherectomy Devices Market Outlook, By Rotational Atherectomy Sevices (2014-2022) ($MN)
Table 43 RoW Atherectomy Devices Market Outlook, By Disease Site (2014-2022) ($MN)
Table 44 RoW Atherectomy Devices Market Outlook, By Coronary artery disease (2014-2022) ($MN)
Table 45 RoW Atherectomy Devices Market Outlook, By Peripheral artery disease (2014-2022) ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abott Laboratories
  • Avinger Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardinal Health (Cordis)
  • Cardiovascular Systems Inc.
  • Cordis Corporation (Subsidiary of J&J)
  • Covidien
  • Medtronic plc.
  • Sp
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll